Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
FOCL
FocalTherics
$4.13
-2.6%
$5.35
$1.30
$6.40
$154.80M-0.04202,222 shs236,361 shs
Health Sciences Acquisitions Co. 2 stock logo
HSAQ
Health Sciences Acquisitions Co. 2
$5.36
-1.3%
$4.13
$9.41
$13.80
$149.23M0.09205,918 shs276,667 shs
Owlet, Inc. stock logo
OWLT
Owlet
$5.23
-6.3%
$5.55
$4.19
$16.94
$151.95M1.85190,692 shs262,682 shs
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
$4.61
-5.9%
$7.71
$4.57
$45.33
$39.64M1.48114,328 shs67,045 shs
10 Best Stocks to Own - Summer 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
FOCL
FocalTherics
0.00%-13.24%-32.18%+412,999,900.00%+412,999,900.00%
Health Sciences Acquisitions Co. 2 stock logo
HSAQ
Health Sciences Acquisitions Co. 2
-3.42%+21.54%+45.26%+32.02%+110.20%
Owlet, Inc. stock logo
OWLT
Owlet
0.00%-22.31%+0.48%-9.36%-27.37%
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
0.00%-2.74%-22.13%-72.38%-88.31%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
FOCL
FocalTherics
$4.13
-2.6%
$5.35
$1.30
$6.40
$154.80M-0.04202,222 shs236,361 shs
Health Sciences Acquisitions Co. 2 stock logo
HSAQ
Health Sciences Acquisitions Co. 2
$5.36
-1.3%
$4.13
$9.41
$13.80
$149.23M0.09205,918 shs276,667 shs
Owlet, Inc. stock logo
OWLT
Owlet
$5.23
-6.3%
$5.55
$4.19
$16.94
$151.95M1.85190,692 shs262,682 shs
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
$4.61
-5.9%
$7.71
$4.57
$45.33
$39.64M1.48114,328 shs67,045 shs
10 Best Stocks to Own - Summer 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
FOCL
FocalTherics
0.00%-13.24%-32.18%+412,999,900.00%+412,999,900.00%
Health Sciences Acquisitions Co. 2 stock logo
HSAQ
Health Sciences Acquisitions Co. 2
-3.42%+21.54%+45.26%+32.02%+110.20%
Owlet, Inc. stock logo
OWLT
Owlet
0.00%-22.31%+0.48%-9.36%-27.37%
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
0.00%-2.74%-22.13%-72.38%-88.31%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
FOCL
FocalTherics
2.40
Hold$7.7587.65% Upside
Health Sciences Acquisitions Co. 2 stock logo
HSAQ
Health Sciences Acquisitions Co. 2
0.00
N/AN/AN/A
Owlet, Inc. stock logo
OWLT
Owlet
2.40
Hold$15.00186.81% Upside
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
2.50
Moderate Buy$51.001,006.29% Upside

Current Analyst Ratings Breakdown

Latest SNWV, FOCL, OWLT, and HSAQ Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/17/2026
FOCL
FocalTherics
Reiterated RatingSell (D-)
8/14/2026
FOCL
FocalTherics
Reiterated RatingNeutral$4.00
8/13/2026
Owlet, Inc. stock logo
OWLT
Owlet
UpgradeSell (E+)Sell (D-)
8/11/2026
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
UpgradeHold (C-)Hold (C)
7/31/2026
Owlet, Inc. stock logo
OWLT
Owlet
Reiterated RatingSell (E+)
7/17/2026
FOCL
FocalTherics
Set Price TargetOutperform$15.00
7/17/2026
FOCL
FocalTherics
UpgradeStrong-Buy
6/24/2026
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
Reiterated RatingHold (C-)
6/22/2026
Owlet, Inc. stock logo
OWLT
Owlet
Reiterated RatingBuy$13.00 ➝ $10.00
6/2/2026
FOCL
FocalTherics
Reiterated RatingBuy$10.00
(Data available from 8/23/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
FOCL
FocalTherics
$70.53M2.19N/AN/A($0.09) per share-45.89
Health Sciences Acquisitions Co. 2 stock logo
HSAQ
Health Sciences Acquisitions Co. 2
N/AN/AN/AN/A($0.62) per shareN/A
Owlet, Inc. stock logo
OWLT
Owlet
$105.70M1.45N/AN/A$0.79 per share6.62
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
$44.05M0.90$1.69 per share2.72$0.32 per share14.41
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
FOCL
FocalTherics
-$29.25M-$1.03N/AN/AN/A-56.26%-248.00%-44.69%8/27/2026 (Estimated)
Health Sciences Acquisitions Co. 2 stock logo
HSAQ
Health Sciences Acquisitions Co. 2
-$380KN/AN/AN/AN/AN/AN/A-2.38%N/A
Owlet, Inc. stock logo
OWLT
Owlet
-$39.68M-$0.75N/AN/AN/A-8.61%-601.24%-15.96%N/A
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
$11.81M$0.2419.21N/AN/A32.38%1,728.10%39.04%11/6/2026 (Estimated)

Latest SNWV, FOCL, OWLT, and HSAQ Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/27/2026Q2 2026
FOCL
FocalTherics
-$0.2287N/AN/AN/A$22.48 millionN/A
8/14/2026Q2 2026
FOCL
FocalTherics
-$0.20-$0.39-$0.19-$0.39N/A$13.20 million
8/11/2026Q2 2026
Owlet, Inc. stock logo
OWLT
Owlet
-$0.09-$0.05+$0.04-$0.05$31.71 million$33.87 million
8/6/2026Q2 2026
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
-$0.03-$0.08-$0.05-$0.08$11.50 million$9.74 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
FOCL
FocalTherics
N/AN/AN/AN/AN/A
Health Sciences Acquisitions Co. 2 stock logo
HSAQ
Health Sciences Acquisitions Co. 2
N/AN/AN/AN/AN/A
Owlet, Inc. stock logo
OWLT
Owlet
N/AN/AN/AN/AN/A
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
FOCL
FocalTherics
1.79
1.60
0.99
Health Sciences Acquisitions Co. 2 stock logo
HSAQ
Health Sciences Acquisitions Co. 2
N/A
0.17
0.61
Owlet, Inc. stock logo
OWLT
Owlet
N/A
1.64
1.33
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
4.87
1.28
0.89

Institutional Ownership

CompanyInstitutional Ownership
FOCL
FocalTherics
62.74%
Health Sciences Acquisitions Co. 2 stock logo
HSAQ
Health Sciences Acquisitions Co. 2
89.71%
Owlet, Inc. stock logo
OWLT
Owlet
72.60%
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
42.53%

Insider Ownership

CompanyInsider Ownership
FOCL
FocalTherics
10.10%
Health Sciences Acquisitions Co. 2 stock logo
HSAQ
Health Sciences Acquisitions Co. 2
21.90%
Owlet, Inc. stock logo
OWLT
Owlet
36.17%
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
14.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
FOCL
FocalTherics
23037.48 million33.70 millionN/A
Health Sciences Acquisitions Co. 2 stock logo
HSAQ
Health Sciences Acquisitions Co. 2
411.21 million8.76 millionNot Optionable
Owlet, Inc. stock logo
OWLT
Owlet
10629.22 million18.65 millionNo Data
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
408.60 million7.36 millionN/A

Recent News About These Companies

Sanuwave Health Q2 Earnings Call Highlights
Sanuwave Announces Q2 FY2026 Financial Results
Sanuwave Health Updates Second Quarter 2026 Guidance

New MarketBeat Followers Over Time

Media Sentiment Over Time

FocalTherics NASDAQ:FOCL

$4.13 -0.11 (-2.59%)
As of 08/21/2026 04:00 PM Eastern

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST). The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment also offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; Ablatherm Fusion that incorporates the company's proprietary fusion software, which merges MRI and ultrasound images; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology; and offers Sonolith i-move, an extracorporeal shockwave lithotripter to small and mid-size hospitals, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. The company markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. Its customers include hospitals, urology clinics, and research institutions. The company was incorporated in 1979 and is headquartered in Lyon, France.

Health Sciences Acquisitions Co. 2 stock logo

Health Sciences Acquisitions Co. 2 NASDAQ:HSAQ

$5.36 -0.07 (-1.29%)
As of 08/21/2026

Health Sciences Acquisitions Corporation 2 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses in the biopharma and medical technology sectors in North America or Europe. Health Sciences Acquisitions Corporation 2 was incorporated in 2020 and is based in New York, New York.

Owlet stock logo

Owlet NYSE:OWLT

$5.23 -0.35 (-6.27%)
As of 08/21/2026 03:58 PM Eastern

Owlet, Inc. provides digital parenting solutions in the United States and internationally. The company's platform focuses on giving real-time data and insights to parents. It offers Dream Sock, a wearable infant health monitor equipped with pulse oximetry technology to track vitals signs, such as pulse rate, oxygen, activity, and sleep patterns; BabySat which is intended for infants with heightened health risk; Owlet Cam, a monitoring device in smartphones that offers video and audio, predictive sleep insights, and cry detections; and accessories, including Owlet Sleeper, as well as Duo and Dream Duo that combines Smart Sock with the Owlet Cam. The company was founded in 2012 and is headquartered in Lehi, Utah.

Sanuwave Health stock logo

Sanuwave Health NASDAQ:SNWV

$4.61 -0.29 (-5.92%)
As of 08/21/2026 04:00 PM Eastern

SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures. The company's lead regenerative product is the dermaPACE device for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. In addition, it offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds; and orthoPACE system to treat tendinopathies and acute and nonunion fractures. The company was founded in 2005 and is headquartered in Suwanee, Georgia.